Wai Chun Bio-Technology Ltd.'s market cap is currently HK$23.15M. The company's EPS TTM is HK$-0.257; its P/E ratio is ―; Wai Chun Bio-Technology Ltd. is scheduled to report earnings on March 27, 2025, and the estimated EPS forecast is HK$―. See an overview of income statement, balance sheet, and cash flow financials.

	Jun 23	Jun 22	Dec 20	Dec 19	Dec 18
Income Statement
Total Revenue	HK$ 773.65M	HK$ 671.46M	HK$ 567.55M	HK$ 579.23M	HK$ 480.85M
Gross Profit	HK$ 50.41M	HK$ 60.12M	HK$ 48.93M	HK$ 49.03M	HK$ 15.52M
Operating Income	HK$ 14.89M	HK$ 20.81M	HK$ 11.15M	HK$ 17.28M	HK$ -51.97M
EBITDA	HK$ 14.89M	HK$ 31.61M	HK$ 17.52M	HK$ 22.61M	HK$ -47.62M
Net Income	HK$ -15.43M	HK$ -14.36M	HK$ 995.00K	HK$ 8.99M	HK$ -53.62M
Balance Sheet
Cash & Short-Term Investments	HK$ 6.31M	HK$ 7.52M	HK$ 5.45M	HK$ 5.41M	HK$ 4.54M
Total Assets	HK$ 240.23M	HK$ 249.95M	HK$ 188.32M	HK$ 176.18M	HK$ 146.74M
Total Debt	HK$ 134.34M	HK$ 151.28M	HK$ 129.78M	HK$ 99.27M	HK$ 96.15M
Net Debt	HK$ 128.02M	HK$ 143.76M	HK$ 124.33M	HK$ 93.86M	HK$ 91.61M
Total Liabilities	HK$ 229.69M	HK$ 243.91M	HK$ 201.29M	HK$ 212.69M	HK$ 192.02M
Stockholders' Equity	HK$ -35.01M	HK$ -37.73M	HK$ -37.49M	HK$ -50.32M	HK$ -47.05M
Cash Flow
Free Cash Flow	HK$ 17.23M	HK$ -16.40M	HK$ -12.96M	HK$ 1.32M	HK$ -13.45M
Operating Cash Flow	HK$ 45.41M	HK$ 390.00K	HK$ -413.00K	HK$ 14.27M	HK$ -6.89M
Investing Cash Flow	HK$ -28.18M	HK$ -16.69M	HK$ -12.52M	HK$ -12.77M	HK$ -2.50M
Financing Cash Flow	HK$ -17.90M	HK$ 17.07M	HK$ 11.53M	HK$ -868.00K	HK$ 8.50M

Currency in HKD

Wai Chun Bio-Technology Ltd. Earnings and Revenue History

Income Statement >

Wai Chun Bio-Technology Ltd. Debt to Assets

Balance Sheet >

Wai Chun Bio-Technology Ltd. Cash Flow

Cash Flow >

Wai Chun Bio-Technology Ltd. Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing